Recent Updates
Recently added Catalysts
RMD Positive Sentiment

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

Key Takeaway: Resmed has announced the release date for its second quarter fiscal 2026 earnings, scheduled for January 29, 2026. The financial results will be discussed in a webcast following the release. Resmed emphasizes its commitment to innovative health technologies that enhance patient care and well-being.
Price reaction · baseline $250.92 (2026-01-08 close) · hit pre-market · 1 other RMD headline(s) in the window, move may be shared
day 0 close
+0.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Resmed is set to report its financial results, indicating ongoing business activity.
  • The company is committed to innovative health technologies that improve lives.
  • The earnings call will provide insights into the company's performance and future outlook.

Full Press Release Details

SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
Location: https://investor.resmed.com
Date: Thursday, January 29, 2026
Time: 1:30 p.m. PST / 4:30 p.m. EST
International: London, Thursday, January 29, 2026, 9:30 p.m. GMT
Sydney, Friday, January 30, 2026, 8:30 a.m. AEDT
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from January 29, 2026, until February 12, 2026, at:
About ResmedResmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
For investors For media
+1 858.221.3304 +1 619.510.1281
investorrelations@Resmed.com news@Resmed.com

Frequently Asked Questions

When will Resmed report its Q2 fiscal 2026 earnings?

Resmed will report its Q2 fiscal 2026 earnings on January 29, 2026.

How can I access the Resmed earnings call?

The earnings call can be accessed via a webcast link provided by Resmed.

Will there be a replay of the earnings webcast?

Yes, a replay of the earnings webcast will be available on Resmed's investor relations website.

What is Resmed's focus in healthcare?

Resmed focuses on creating innovative health technologies to improve sleep and breathing.

Last updated: Jan 9, 2026